tradingkey.logo

Doximity rises after Raymond James upgrades to 'strong buy'

ReutersNov 21, 2025 6:07 PM

Shares of telehealth company Doximity up 8.8% at $50.47

Raymond James upgrades to "strong buy" from "outperform" rating; PT at $65

Brokerage sees potential from AI monetization and possible shifts toward direct-to-consumer for healthcare providers, which could support above-market growth

Sees long-term growth visibility and durability continues to improve

11 of 21 brokerages rate the stock "buy" or higher, 10 "hold"; their median PT is $65 - data compiled by LSEG

As of last close, stock down ~13% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI